Silica Nanoparticle-Induced Structural Reorganizations in Pulmonary Surfactant Films: What Monolayer Compression Isotherms Do Not Say

The interaction of nanoparticles (NPs) with pulmonary surfactant is important for understanding the potential adverse effects of inhaled engineered and incidental nanomaterials. The effects of a low concentration (0.001 wt %) of charged, hydrophilic silica NPs of hydrodynamic diameter of ∼20 nm on the phase behavior and lateral structure of lipid-only and naturally derived surfactant monolayers were investigated at the air/water interface using surface pressure–area isotherms and Brewster angle microscopy, respectively. Atomic force microscopy was used to image the morphology of films transferred onto mica substrate with nanometer resolution. We show that the silica NPs can significantly alter the condensed domain size and shape even in the absence of apparent differences in the monolayer compression isotherms. The cationic particles notably induce structural and morphological progressions in a binary model containing anionic phosphoglycerol that are similar to those observed for the natural surfactant fi...

[1]  J. Zasadzinski,et al.  More than a monolayer: relating lung surfactant structure and mechanics to composition. , 2004, Biophysical journal.

[2]  J. Zasadzinski,et al.  Lipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayers. , 2012, Biophysical journal.

[3]  M. Maskos,et al.  Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems. , 2014, Biophysical journal.

[4]  R. Veldhuizen,et al.  Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. , 2007, Biophysical journal.

[5]  P. Byron.  Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. , 1986, Journal of pharmaceutical sciences.

[6]  Yves F. Dufrêne,et al.  Nanometer-scale surface properties of mixed phospholipid monolayers and bilayers , 1997 .

[7]  A. Kummel,et al.  Synthesis and surface functionalization of silica nanoparticles for nanomedicine. , 2014, Surface science reports.

[8]  M. Bakshi,et al.  Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. , 2008, Biophysical journal.

[9]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[10]  J. Loo,et al.  Increasing Hydrophobicity of Nanoparticles Intensifies Lung Surfactant Film Inhibition and Particle Retention , 2014 .

[11]  A. Cruz,et al.  Barrier or carrier? Pulmonary surfactant and drug delivery. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  V. Rotello,et al.  The role of surface functionality in determining nanoparticle cytotoxicity. , 2013, Accounts of chemical research.

[13]  J. Hohlfeld,et al.  Interaction of nanoparticles with the pulmonary surfactant system , 2009, Inhalation toxicology.

[14]  Sijin Liu,et al.  Computational Investigations of the Interaction between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant. , 2018, ACS applied materials & interfaces.

[15]  R. Veldhuizen,et al.  Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films. I. Micro- and nanostructures of functional pulmonary surfactant films and the effect of SP-A. , 2008, Biophysical journal.

[16]  E. Prenner,et al.  Differential interactions of gelatin nanoparticles with the major lipids of model lung surfactant: changes in the lateral membrane organization. , 2015, The journal of physical chemistry. B.

[17]  M. Forrest,et al.  Phospholipid composition modulates carbon nanodiamond-induced alterations in phospholipid domain formation. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[18]  A. Farnoud,et al.  Interaction of dipalmitoyl phosphatidylcholine monolayers with a particle-laden subphase. , 2013, The journal of physical chemistry. B.

[19]  K. Kjaer,et al.  X-ray diffraction and reflectivity validation of the depletion attraction in the competitive adsorption of lung surfactant and albumin. , 2009, Biophysical journal.

[20]  Libo Li,et al.  Molecular Understanding of the Penetration of Functionalized Gold Nanoparticles into Asymmetric Membranes. , 2017, Langmuir : the ACS journal of surfaces and colloids.

[21]  G. Lajoie,et al.  Characterization of bovine surfactant proteins B and C by electrospray ionization mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[22]  T. Sosnowski.  Particles on the lung surface - physicochemical and hydrodynamic effects , 2018, Current Opinion in Colloid & Interface Science.

[23]  Qihui Fan,et al.  Comparative study of clinical pulmonary surfactants using atomic force microscopy. , 2011, Biochimica et biophysica acta.

[24]  Matthias Ochs,et al.  Interactions of nanoparticles with pulmonary structures and cellular responses. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[25]  S. Tatur,et al.  Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[26]  A. Barron,et al.  Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics. , 2007, Colloids and surfaces. B, Biointerfaces.

[27]  E. Guzmán,et al.  Effect of the Incorporation of Nanosized Titanium Dioxide on the Interfacial Properties of 1,2-Dipalmitoyl-sn-glycerol-3-phosphocholine Langmuir Monolayers. , 2017, Langmuir : the ACS journal of surfaces and colloids.

[28]  Peter R. Byron,et al.  Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.

[29]  Liangfang Zhang,et al.  Nanoparticle-induced surface reconstruction of phospholipid membranes , 2008, Proceedings of the National Academy of Sciences.

[30]  Qihui Fan,et al.  Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona. , 2013, ACS nano.

[31]  E. Guzmán,et al.  DPPC–DOPC Langmuir monolayers modified by hydrophilic silica nanoparticles: Phase behaviour, structure and rheology , 2012 .

[32]  Guoqing Hu,et al.  Unveiling the Molecular Structure of Pulmonary Surfactant Corona on Nanoparticles. , 2017, ACS nano.

[33]  Jiaqi Lin,et al.  Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship. , 2010, ACS nano.

[34]  E. Guzmán,et al.  Effect of Hydrophilic and Hydrophobic Nanoparticles on the Surface Pressure Response of DPPC Monolayers , 2011 .

[35]  L. Godderis,et al.  Toxicology of silica nanoparticles: an update , 2017, Archives of Toxicology.

[36]  M. Maccarini,et al.  Effect of functionalized gold nanoparticles on floating lipid bilayers. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[37]  R. Larson,et al.  Modeling the Hydrophobicity of Nanoparticles and Their Interaction with Lipids and Proteins. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[38]  J. Zasadzinski,et al.  Nanostructure changes in lung surfactant monolayers induced by interactions between palmitoyloleoylphosphatidylglycerol and surfactant protein B , 2003 .

[39]  N. Wilke,et al.  Phase coexistence in films composed of DLPC and DPPC: a comparison between different model membrane systems. , 2014, Biochimica et biophysica acta.

[40]  S. Pillai,et al.  Toxicity of Nanomaterials: Exposure, Pathways, Assessment, and Recent Advances. , 2018, ACS biomaterials science & engineering.

[41]  D. Vollhardt,et al.  Thermodynamic and textural characterization of DPPG phospholipid monolayers. , 2000 .

[42]  P. Prasad,et al.  Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy. , 2016, Chemical reviews.

[43]  F. Walther,et al.  KL₄ peptide induces reversible collapse structures on multiple length scales in model lung surfactant. , 2011, Biophysical journal.

[44]  Rajesh R Naik,et al.  Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption. , 2012, Journal of the American Chemical Society.

[45]  J. Pérez-Gil,et al.  Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. , 2008, Biochimica et biophysica acta.

[46]  Qihui Fan,et al.  On the low surface tension of lung surfactant. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[47]  J. Loo,et al.  Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. , 2011, ACS nano.

[48]  J. Pérez-Gil,et al.  Pulmonary surfactant pathophysiology: current models and open questions. , 2010, Physiology.

[49]  A. Kraegeloh,et al.  Interactions between DPPC as a component of lung surfactant and amorphous silica nanoparticles investigated by HILIC-ESI-MS. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[50]  D. Vollhardt,et al.  Effect of molecular chirality on the morphology of biomimetic langmuir monolayers. , 2003, Chemical reviews.